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The current study presents a descriptive chronological survey of the articles published by Césaire Auguste Phisalix
and Albert Calmette on snake poison, with the aim of shedding a light on the areas of research and reasoning
followed by these scientists, leading up to their simultaneous discovery of antivenom serotherapy in 1894. The path
taken by Phisalix is revealed in 15 articles that demonstrate the motivation of a naturalist and the way he
confronted the puzzle of immunity against snake venom. In the case of Calmette, two articles preceded the
discovery; microbiology was his theoretical base and the Pasteurian spirit of solving health problems his driving
force. These two researchers followed distinct paths, mobilized by different motivations, but produced one single
result. It is incontestable that the discovery of antivenom serotherapy was the work of two groups of researchers
who deserve equal recognition, but who, in fact, did not receive it. Following the discovery both Calmette and
Phisalix returned to their previous motivations. Calmette put the discovery into practice and began to produce
antivenom serum in Lille. He came to be generally considered as the sole discoverer of antivenom serotherapy and
was the recipient of a number of prestigious prizes. Phisalix, on the other hand, received little recognition and
returned to his original interests, devoting himself to research on natural immunity. In Brazil, the discovery of
antivenom serum therapy had a profound impact on the work of Vital Brazil Mineiro da Campanha, a researcher
known worldwide for his scientific discoveries and for the evidence of the specificity of antivenom serums.
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Background
The discovery of antivenom serotherapy, which occurred
in France, was presented to the French Society of Biol-
ogy on the 10th of February 1894 by representatives of
two Parisian research institutions. The organizations were
the National Museum of Natural History, represented by
Césaire Auguste Phisalix and Gabriel Bertrand, under the
direction of Jean Baptiste Auguste Chauveau, and the
Pasteur Institute, represented by Albert Calmette, under
the direction of Emile Roux [1, 2].
A number of scientific events, both in the area of mi-
crobial therapy and in the specific subject of animal
venom associated with immunization and natural im-
munity, created a fertile ground for this discovery to
occur. Concerning microbial therapy, Bon [3] mentions
only the identification of diphtheria and tetanus toxins,
and the discovery of serum therapy as major findings.
However, the following events were also important for
the development of this field:
 the first vaccination against smallpox by Edward
Jenner on May 14, 1796 [4];
 Pasteur’s virus attenuation and vaccination against
avian cholera in 1880 [5];
 vaccination against anthrax by Louis Pasteur,
Charles Chamberland and Émile Roux in 1881 [6];
 discovery of the tuberculosis bacillus by Robert
Koch in 1882 [7];
 vaccination against rabies by Louis Pasteur in 1885 [8];
 development of immunity against Staphylococcus
pyosepticus after peritoneal transfusion observed by
Jules Héricourt and Charles Richet in 1888 [9];
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 identification of the diphtheria toxin by Émile Roux
and Alexandre Yersin in 1888 [10];
 publication of immunity studies by Metchnikoff in
1889 [11];
 identification of the tetanus toxin by Knud Faber in
1890 [12];
 discovery of antitoxins by Emil Von Behring and
Shibasaburo Kitasato in 1890 [12].
Regarding venoms, immunization and natural immun-
ity, Bon [3] mentions only works related to immunization:
those of the Italian Domenico Fornara [13], the English
Henry Sewal [14] and the French Maurice Kaufmann [15].
The following events, however, are worthy of recognition
in this context:
 verification of the natural immunity of vipers and
non-venoms snakes against viper venom by Felice
Fontana in 1781 [16, 17];
 identification, in Vipera berus venom, of a protein
called “vipérine” or “échidnine” similar to digestive
enzymes by Lucien Bonaparte in 1841–1843 [16, 18];
 the discovery of active alkaloid principles in the
poisons of frogs and salamanders by Pierre Louis
Gratiolet and Stanislas Cloëz in 1852 [16, 19];
 the immunization of dogs against frog venom by
Domenico Fornara in 1877 [16, 20];
 the extraction of an alkaloid from the venom of
Salamandre terrestre by Zalesky in 1886 [16, 21, 22];
 the development of resistance in pigeons against the
venom of Crotalus snakes by means of the injection
of increasing doses of the venom by Henry Sewall in
1887 [14];
 the development of the theory that successive
inoculations of low doses of venom may provoke a
certain degree of immunity against higher doses by
Maurice Kaufmann in 1889 [23]; and
 proof that successive inoculations of small amounts
of venom may produce resistance, but are incapable
of conferring true immunity against envenomation,
by Maurice Kaufmann in 1892 [15].
It is incontestable that the discovery of antivenom ser-
otherapy was the work of two groups of researchers who
deserve equal recognition, but who, in fact, did not re-
ceive it. Even though in 1894 the French Academy of
Sciences bestowed the Montyon Prize on Césaire
Auguste Phisalix and Gabriel Bertrand for their discov-
ery [24], and in 1898 gave the Bréant Prize to Césaire
Auguste Phisalix for the sum of his work on venom and
poisonous animals [25], it was in reality Albert Calmette
who received all the recognition for the discovery.
Several scientific studies – such as those by Abelardo
Sáenz [26], Arlindo de Assis [27], Bernard [28–30],
Bernard and Nègre [31], Chung and Biggers [32],
Gernez-Rieux [33], Guénel [34], Klobusitzky [35], Leake
[36] and Rivière and Bon [37] –indicate Calmette as the
unique discoverer of antivenom serotherapy, leaving
Phisalix in the most profound anonymity. Many factors
contributed to this situation: the premature death of Phi-
salix in 1906, at only 54 years of age; the departure of
Gabriel Bertrand from the National Museum of Natural
History in 1900 to work on other areas in the Pasteur
Institute in Paris; and the efforts of Calmette, in contrast
to those of Phisalix, in advertising his work at home and
abroad. Moreover, and most importantly, Calmette began
to produce antivenom serum at the Pasteur Institute in
Lille, putting his discovery into practice. For his part,
Phisalix returned to his original interests and dedicated
himself to his studies on natural immunity.
Within the context of this simultaneous discovery, a
question arises: how is it that two groups from distinct
institutions made the same discovery at the same time?
In order to address this question, the present work un-
dertakes a descriptive and chronological analysis of the
articles published by Césaire Auguste Phisalix and Albert
Calmette on the subject of animal venom, with the aim
of presenting their motivations and the process of rea-
soning followed by these researchers, which led them to
the simultaneous discovery of antivenom serotherapy.
The work of Césaire Auguste Phisalix on animal venom
before the discovery of antivenom serotherapy
Phisalix published his first work on animal venom in
August 1889 in the journal Association française pour
l’avancement des sciences. This first one and the four
subsequent articles were published between 1889 and
1891. One of them was written in collaboration with P.
Langlois and another with Charles Louis Contejean.
These studies were related to the poison of the terres-
trial salamander and mentioned:
 the efficacy of the poison lethal dose was dependent
on the mean of inoculation into the organism;
 immunity could be developed though administration
of successive doses of poison;
 the non-refractory state of the salamander with
respect to its own poison;
 the effect of salamander poison on the nervous
system, temperature, breathing and movement of
mammals;
 the two types of cutaneous glands (mucous and
specific); and
 the type of secretion, whether acid or alkaline
[22, 23, 38–40].
Afterwards, Phisalix began to study frog venom and in
1893 published, with Gabriel Bertrand, his first two works
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on the subject. They concluded that frog blood contained
active substances possessing the same physiological prop-
erties as its poison, but at a low concentration. These ac-
tive elements, products of the internal secretion of the
cutaneous glands, would be responsible for the relative
immunity of the frog to its own poison [41, 42].
In August 1893, Phisalix published a work on the tox-
icity of the blood of the terrestrial salamander, in which
he concluded that it contains a toxin similar to that se-
creted by the poison glands and which reaches the blood
by means of an internal secretion mechanism [43].
In December of the same year, in partnership with
Gabriel Bertrand, Phisalix began his studies on the tox-
icity of snake blood. The two explained their choice of
this animal based on the existing opposition between the
composition and properties of this venom and those of
frog and salamander poison. They concluded that snake
blood contains some principles analogous to those of
the venom, which are endowed with great physiological
activity and stem from internal secretions of the glands.
The presence of these toxic principles in the blood must
be considered the true cause of snake immunity against
its own venom [44].
In January 1894, Phisalix and Bertrand, both influ-
enced by the naturalist vision, returned to the subject of
natural immunity. They published a work on the pres-
ence of venom glands in non-venomous snakes and the
toxicity of their blood. They observed that there are
toxic substances analogous to “échidnine” in the blood
of non-venomous snakes, which is the result of the in-
ternal secretion of the upper labial glands, and that the
physiological and chemical similarity of these principles
to “échidnine” explains the immunity of these animals to
viper venom [45].
Still in January 1894, Phisalix and Gley published an
article about the effects of thyroid removal on salaman-
ders, in which they concluded that this procedure could,
in the case of inferior invertebrates, produce serious ef-
fects and even death [46].
In spite of Phisalix’s medical training, it is important to
emphasize that in these early 11 studies, he approached
only topics related to naturalists’ interests. His motivation
was derived from animal biology to the detriment of
human therapeutics.
Nevertheless, a new direction came to be followed in
his research at the beginning of 1894. At this time,
Phisalix and Bertrand returned to their studies on the
toxicity of viper blood and its venom. In the article pub-
lished in the Archives de physiologie normale et patholo-
gique, they confirmed that viper venom is in part
destroyed or weakened by heat in accordance with the
intensity and duration of heat exposure. They also sug-
gested an analogy between venom and microbial toxins
when they stated: “the porcelain filters hold the toxic
material just as they hold microbial toxins” 1 [47]. They
concluded that there are in viper blood toxic principles
analogous to those of venom, which have the same
chemical and physiological properties. Consequently,
viper immunity to its own venom is due to an internal
secretion from specific glands, in such a manner that
its active principles impregnate the organism and cre-
ate a familiarity with large doses of this powerful
venom [47].
On February 5, 1894, Phisalix and Bertrand presented
their experiments on the weakening of viper venom by
heating and the vaccination of a guinea pig against it.
They confirmed that the heated venom becomes a vac-
cine while small doses of the venom in its natural state
provoke only a progressive and slow familiarity, but not
a genuine immunization. They also came to the follow-
ing conclusions: there are two toxic substances in the
venom, one acts in a manner comparable to certain dia-
stases, and to which they gave the name “échidnase”.
The other substance, which they called “échidnotoxine”,
has a strong general effect on the nervous system, dis-
rupting the functioning of the vasomotor apparatus to
the point of causing death. When given to guinea pigs, it
produces serious hypothermia. Both two substances can
be considerably altered, if not destroyed, by tempera-
tures of around 75 °C [48].
Following this, Phisalix and Bertrand deepened their
research on the causes of natural immunity in non-
venomous snakes. They assumed that the immunity of
these animals to viper venom resulted from the presence
in their blood of toxic principles analogous to those of the
venom. Such substances are also found in the upper labial
glands of non-venomous snakes and are not only homolo-
gous to the venom glands of the vipers, but are indeed
analogous, at least regarding the internal secretion [49].
It is important to note that before February 5, 1894,
when Phisalix announced his findings on the weakening
of viper venom by heating and the vaccination of a
guinea pig against this venom, he had never explicitly
shown any interest in therapy or for the treatment of
cases of envenomation.
It is possible that his interest was awakened following
a conversation with Elie Metchnikoff, as Albert Calmette
states in a letter to his parents from February 13, 1894:
“Two weeks ago, just after my first communication
about the toxicity of snake blood, Messrs. Phisalix and
Bertrand, two scholars of the museum (said to be quite
bad experimenters) asked Metchnikoff at the Biology
Society if I could supply them with a small quantity of
snake venom. Metchnikoff replied to them that my work
was almost completed, that I probably had no venom left.
In any case, it was of little use to devote time to work on
this question because my research was very advanced, that
I had discovered not only immunization of animals, but
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also the cure, etc. – Three days later, Phisalix and Bertrand
read a note to the Academy of Sciences in which they
reproduced for their own benefit what Metchnikoff had
told them, and announced that they had found a way to
immunize animals against poisoning with the help of
heated venom” 2 [50].
On the other hand, it is important to point out that
Phisalix was not only a naturalist. He was trained in
medicine and by 1894 he had already published several
works on microbiology, two of which deserve to be men-
tioned as they are related to the influence of heat on the
sporogenesis of Bacillus anthracis [51, 52]. It is quite
probable that the idea of using heat to attenuate snake
venom had its origins in these two works.
The work of Albert Calmette on venom before the
discovery of antivenom serotherapy
Calmette began his study on snake venom in October,
1891. At that time, he was in Saigon, where he was re-
sponsible for opening a new branch of the Pasteur Insti-
tute. In a letter dated November 7, 1891, Calmette
explained to his parents his motivation to take up the
study of this topic: “Twelve days ago, I launched into the
most interesting experimental research on the venom of
the famous snakes called Najas or capel cobras that
every year kill, in India alone, according to the official
statistics of the English government, 21,000 people! In
Cochinchina, these snakes are rarer. In any case, there is
a good number: a village near Bac-Lieu was invaded by a
multitude of snakes that were fleeing from floodwaters.
The snakes entered homes and bit 40 people, of which
four died almost immediately. An Annamite, part snake
charmer and part wizard, was able to take control of 19
of these animals. The district administrator, an intelli-
gent man, upon learning of this, telegraphed me to ask if
I wanted him to send the snakes to my laboratory, along
with the Annamite who knew how to handle them. Nat-
urally, I accepted immediately, and the snakes arrived in
a barrel. Fourteen of them were still alive. I kept three in
cages and killed 11 in order to extract their venom
glands; with these glands I made a quantity of prepara-
tions that allowed me to obtain venom that is pure, easy
to conserve, and that I have used in very interesting ex-
periments, because never before has it been possible to
preform such a complete study of venom under such fa-
vorable conditions as I have been able to gather” 3 [53].
Calmette’s motivation seems to have been inspired by
the Pasteurian spirit of the age, dedicated to the elimin-
ation of health problems, as well as carrying out research
that could confer recognition and prestige in the inter-
national scientific community [54].
In March, 1892, Calmette published his first work on
snake venom, in Annales de l'Institut Pasteur, in which
he dealt with the following topics:
 the preparation and conservation of venom;
 the physiology of envenomation, covering natural
immunity;
 the means of venom injection;
 the non-transmissibility of envenomation by the blood;
 the physical-chemical properties of venom;
 the action of antiseptics and other chemical
substances;
 attempts to produce artificial immunity against
evenomation, without any success.
Nevertheless, he concluded that it was possible to cure
envenomated animals by neutralizing the venom
absorbed by blood with the help of subcutaneous injec-
tions of gold chloride into the wound itself, around it
and in the upper part of the affected limb. He declared
that this treatment, applied to a human being, would
produce the same results. He believed that the efficacy
of this treatment would likely extend to bites of all
venomous snakes, since the diverse “échidnines”
(vipérine, crotaline, najine, élaphine, etc.) demon-
strated slight differences in physiological action
amongst themselves. Furthermore, all authors who
had conducted experiments with the venom of exotic
snakes were in agreement that the venom of cobra is
the most active [55].
In 1892, Calmette received only a single honorable
mention, in the Barbier Prize from the French Academy
of Medicine, for his work on the curative power of gold
chloride in treating envenomation by Naja tripudians or
cobra capel. This study was discussed in his first article
[55]. The reasons for his losing the prize were explained
as follows: “The bite of this snake is terrible and is re-
sponsible for the deaths, every year, of too great a num-
ber of our soldiers in Cochinchina. Mr. Calmette would
have won the prize if the efficacy of gold chloride had
been demonstrated. Unfortunately, the results that he of-
fered are not convincing” 4 [56].
It was only on January 13, 1894, that Calmette pub-
lished his second work on venom, in which he ana-
lyzed the toxicity of cobra capel blood. In this article,
he cited the research of Phisalix and Bertrand on the
toxicity of viper blood [44]. He confirmed that cobra
capel blood is extremely toxic, that the symptoms of
envenomation are the same as those produced by in-
oculation with venom, that the blood of the cobra is
not venomous for toads, fish, and not even for a small
species of non-venomous snake. He also stated that
the non-venomous snake appeared to be completely
resistant to the venom, in the same way as the cobra,
and that the injection of small non-lethal doses of
pure cobra blood did not confer any immunity to ani-
mals, which succumbed to inoculations of venom
given later [57].
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Phisalix’s crossword puzzle
The cumulative character of science has often been
described as solving a giant crossword puzzle, in
which each piece represents a unit of scientific know-
ledge, with new pieces being placed in the existing
structure [58, 59].
The line of reasoning followed by Phisalix, which lead
to the discovery of antivenom serotherapy, may be inter-
preted as solving a small crossword puzzle made of four
pieces. The first of these was based on Phisalix’s two ar-
ticles on the effect of heat on the sporogenic property of
Bacillus anthracis [51, 52] and was related with the use
of heat to remove toxic properties from toxic microor-
ganisms. The second was based on his work on the com-
parative toxicity of the blood and the venom of the
viper, in which the analogy between venom and micro-
bial toxins was verified [47]. The sum of the information
in both articles lead to the fact that viper venom is in
part destroyed or weakened by heat in conformity with
the intensity and duration of the heating. The third piece
stemmed from the work on the weakening of venom by
heat and the vaccination of guinea pigs against this
venom [48]. It was suggested, in that research, that
heated venom becomes a vaccine and its use in small
doses in its natural state produces only a progressive fa-
miliarity, but not a true vaccination. The fourth and final
piece was derived from the work dedicated to the causes
of natural immunity to viper venom in non-venomous
snakes [49]. In estimating that this immunity results from
the presence in the blood of toxic principles analogous to
those in the venom, Phisalix and Bertrand went beyond
the results achieved by Sewall in 1887 and Kaufmann in
1889, who got as far as immunization of animals, but did
not proceed with the topic of treatment with antivenom
serotherapy [14, 23]. They described the transfer of im-
munity from one animal to another (passive immunity),
paving the way for the discovery of antibodies.
Calmette and microbiology
The information contained in the two works by Calmette
on venom published before the discovery of antivenom
serotherapy is not sufficient to provide an understanding
of his line of reasoning [55, 57]. That being the case, it is
necessary to look at his biography, as well as his other
published works, in order to understand the path to his
discovery.
Any understanding of Calmette’s training in microbiol-
ogy should begin with the period between 1888 and
1890, which he spent in Saint Pierre and Miquelon.
While there, in a self-taught way and based on a few
published texts at that time, he performed experimental
research on rouge de morue (the appearance of a reddish
coloration in cods because of contamination by a micro-
organism). Calmette thought of this research as his self-
initiation into microbiological methodology, in which he
isolated the microorganism, identified the conditions
under which it develops, the fact that it originates in salt,
and even that a small quantity of sodium sulfite prevents
its proliferation. He was unable, however, to demonstrate
the toxicity of the microorganism, as the consequences
of the phenomenon were purely commercial, given that
no one wanted to buy the cod when it changed color [54].
Calmette arrived in Paris in 1890 to participate in one of
the first microbiology courses offered by the Pasteur Insti-
tute, taught by Dr. Émile Roux. His three-month stay at
the institute marked an important stage in his life: full of
enthusiasm and admiration for the Pasteurian discoveries,
he decided to abandon his career in naval medicine and
dedicate himself to research. It did not take long for him
to gain the confidence of Émile Roux, who introduced
him to Louis Pasteur. The latter chose Calmette to found
a laboratory in Saigon dedicated to the preparation of vac-
cines for smallpox and rabies. It was there that Calmette
would begin his work on snake poison [59].
According to Calmette, at the time he began his stud-
ies on Naja venom, limited data on its physiology were
available. Only some of its properties had been explained
in the work of Weir Mitchell and Reichard in the USA,
Wall and Armstrong in England, Armand Gautier and
Maurice Kaufmann in France and, especially, in the
admirable volume of Sir James Fayer (Thanatophidia
indica), published in London in 1872 [18].
Although Calmette had not completely mastered the
field, which may explain the future controversies that
surrounded him, Phisalix and Vital Brazil [20], he be-
lieved that he could not miss an excellent opportunity to
study a topic in which interests had increased following
the discoveries by Émile Roux and Behring on the diph-
theria and tetanus toxins [18]. For Calmette, venoms
and envenomations represented a topic that physicians
had rarely focused on, but interests in it had been awak-
ened because of the close connections discovered be-
tween microbial toxins and problems of immunity. He
followed a therapeutic approach and discovered the anti-
venoms in the wake of German, Japanese, English and
French microbiologists [4–12].
Thus, Calmette’s solid experience in microbiology
must have prevailed, providing him a glimpse of the ana-
logy between microbial toxins and venom.
Conclusions
The careful, chronological analysis of the work of these
researchers, along with their biographical information,
helps to understand the lines of reasoning adopted by
each of them.
It is possible to recognize how these two distinct
groups, coming from two important French institutions
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of the period, and arising from different motivations and
paths, came to the same discovery at the same time.
In addition, we should not forget to mention the fertile
ground that existed at the time of the discovery, thanks
to the work of numerous researchers, as much in the
area of microbial therapy as in the more specific field of
immunization and natural immunity.
In conclusion, the analysis of the work of Albert Calmette
and Césaire Auguste Phisalix still serves to confirm the
effervescence of this field at the time, given that a great
number of their precursors were found to be explicitly cited
in their work.
In Brazil, the discovery of antivenom serum therapy had
a profound impact on the work of Vital Brazil Mineiro da
Campanha (1865–1950), a researcher known worldwide
for his scientific discoveries and for his evidence of the
specificity of antivenom serums. He was also responsible
for the creation of the Butantan Institute in São Paulo city,
São Paulo state, and the Vital Brazil Institute in Niteroi,
Rio de Janeiro state [60].
Sharing the work of these researchers, especially that
of Césaire Auguste Phisalix, has become mandatory in
order to ensure that history is told in a more fair and
trustworthy way.
Endnotes
1Original text: "les filtres de porcelaine retiennent la
matière toxique du venin comme ils retiennent les tox-
ines microbiennes".
2Original text: "Il y a 15 jours, à la suite de ma 1ère
communication sur la toxicité du sang des serpents,
MM. Phisalix et Bertrand, deux savants du Muséum
(réputés comme assez mauvais expérimentateurs) ont
demandé à M. Metchnikoff à la Société de Biologie si je
ne pourrais pas mettre à leur disposition un peu de
venin de cobra. M. Metchnikoff leur répondit que mon
travail était presque terminé, que je ne devais plus avoir
beaucoup de venin, et que d’ailleurs il était inutile de se
mettre aussi à travailler cette question des venins car
mes recherches à moi étaient très avancées, que j’avais
trouvé non seulement l’immunisation des animaux mais
même la guérison etc. – Trois jours après, Phisalix et
Bertrand faisaient à l’Académie des Sciences la lecture
d’une note dans laquelle ils reproduisaient pour leur
propre compte ce que leur avait dit M. Metchnikoff,
et ils déclaraient avoir trouvé le moyen d’immuniser
les animaux contre le venin à l’aide d’injections de
venin chauffé".
3Original text: "Depuis une douzaine de jours je suis
lancé dans des recherches expérimentales on ne peut
plus intéressantes sur le venin de ces fameux serpents
qu'on appelle des Najas ou cobras capel et qui tuent cha-
que année, dans l'Inde seule, d'après les statistiques offi-
cielles du gouvernement anglais, 21.000 personnes! En
Cochinchine, ces serpents passent pour plus rares. Or
voici ce qui prouve que, dans tous les cas, il en existe un
bon nombre : un village des environs de Bac-Lieu, pre-
sque envahi par les eaux s'est vu assaillir par une foule
de cobras fuyant devant l'inondation. Les cobras entrai-
ent dans les maisons et ont piqué paraît- il 40 personnes
dont 4 étaient mortes presque aussitôt. Un annamite
moitié psylle et moitié sorcier s'est emparé de 19 de ces
animaux. L'administrateur de l'arrondissement, homme
intelligent, informé du fait m'a aussitôt télégraphié pour
me demander si je voulais qu'il m'envoie au laboratoire
les cobras et l'annamite qui a su les prendre. J'ai accepté
aussitôt, bien entendu, et les serpents me sont arrivés
dans un baril. 14 étaient encore vivants. J'en ai gardé 3
dans des cages, et j'en ai tué onze pour extraire leurs
glandes à venin; avec ces glandes j'ai fait une quantité de
préparations qui m'ont permis d'obtenir du venin pur,
facile à conserver, et je l'emploie à des expériences dont
l'intérêt est très grand parce que jamais une étude aussi
complète du venin n'a pu être tentée dans des conditions
aussi favorables que celles que j'ai pu réunir".
4Original text: "La morsure de ce serpent est redouta-
ble, et fait périr chaque année en Conchinchine un trop
grand nombre de nos soldats. Aussi M. Calmette aurait-
il obtenu un prix si l’efficacité du chlorure d’or eût été
démontrée. Malheureusement les preuves qu’il fournit
ne sont pas convaincantes".
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